FindTrial
Sign In

A study to find the relationship between glucose level changes before, during and after surgery, determined by continuous glucose monitoring devices, and early results in adults undergoing non- emergency coronary artery bypass grafting with heart lung machine

Association between perioperative glycemic variations determined by Continuous glucose monitoring system and early postoperative outcomes in adults undergoing elective Coronary artery bypass grafting with Cardiopulmonary bypass- A Pilot Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/057116
Enrollment
30
Registered
2023-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I20-I25- Ischemic heart diseases

Interventions

Intervention1: NIL: NIL

Sponsors

Department of Anaesthesiology Critical Care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ALL ADULTS AGED MORE THAN 18 YEARS. BOTH MALES AND FEMALES SCHEDULED FOR ELECTIVE CABG WITH CARDIOPULMONARY BYPASS AT THE STUDY INSTITUTION. WILLING TO WEAR THE CGM SENSOR ON THE ARM FOR THE STUDY DURATION

Exclusion criteria

Exclusion criteria: PATIENTS WHO DONOT GIVE CONSENT TO PARTICIPATE IN THE STUDY PATIENTS UNDERGOING EMERGENCY CARDIAC SURGERIES PATIENTS WITH SURGERY FOR VALVULAR HEART DISEASE PATIENTS UNDERGOING CABG SURGERY ALONG WITH VALVULAR REPAIR/ REPLACEMENT. HISTORY OF ATRIAL FIBRILLATION BEFORE SURGERY PATIENTS REQUIRING PREOPERATIVE MECHANICAL VENTILLATORY SUPPORT PATIENTS REQUIRING PREOPERATIVE VASOACTIVE MEDICATION SUPPORT FOR HEMODYNAMIC STABILITY PATIENTS WILLING TO WEAR THE CGM SENSOR ON THE ARM FOR THE ENTIRE STUDY PERIOD

Design outcomes

Primary

MeasureTime frame
Total dose of vasoactive medications required in post operative period upto post operative day 1 in adults undergoing elective CABG with cardiopulmonary bypassTimepoint: Day of operation & postoperative day 1—

Secondary

MeasureTime frame
Total duration of ICU stay Duration of postoperative invasive mechanical ventillation Incidence of postoperative atrial fibrillation Incidence of surgical site infection Incidence of cardiac arrest & mortality in perioperative periodTimepoint: From day of surgery till postoperative day 10—

Countries

India

Contacts

Public ContactDR D V BHARGAVA

ARMED FORCES MEDICAL COLLEGE, PUNE

dv5913@gmail.com8411075937

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026